About GLS Pharma
GLS Pharma is a company based in Delhi (India) founded in 2004 was acquired by Aurobindo Pharma in June 2022. The company has 116 employees as of April 03, 2024.
- Headquarter Delhi, India
- Employees 116 as on 03 Apr, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Gls Pharma Limited
- Date of Incorporation 01 Sep, 2004
- Jurisdiction Seri Lingampally, Telangana, India
-
Annual Revenue
$4.34 M (USD)13862.3as on Mar 31, 2023
-
Net Profit
$228.18 K (USD)8628.69as on Mar 31, 2023
-
EBITDA
$633.37 K (USD)12459.1as on Mar 31, 2023
-
Latest Funding Round
Not available
- Investors
-
Employee Count
116
as on Apr 03, 2024
-
Acquired by
Aurobindo Pharma
(Jun 17, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of GLS Pharma
Detailed funding history for GLS Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in GLS Pharma
GLS Pharma has secured backing from 1 investor. Prominent investors backing the company include Aurobindo Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
Locked | Locked | Locked |
Investor details for GLS Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by GLS Pharma
Investment portfolio details for GLS Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - GLS Pharma
Detailed financials for GLS Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Gls Pharma Comparisons
Peer comparison for GLS Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of GLS Pharma
Detailed competitors of GLS Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Gls Pharma
Complete news archive for GLS Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GLS Pharma
GLS Pharma was founded in 2004.
GLS Pharma is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
As of Apr 03, 2024, the latest employee count at GLS Pharma is 116.
Annual revenue of GLS Pharma is $4.34M as on Mar 31, 2023.
Founded in 2004 in Delhi, India, operations in the oncology pharmaceutical sector are conducted by GLS Pharma. Active pharmaceutical ingredients and finished formulations for solid and hematological malignancies are produced, along with supportive care therapies. Stringent quality standards are followed in manufacturing processes. Backward integration is utilized to manage costs while quality is preserved.
GLS Pharma has 1 investor. Key investors include Aurobindo Pharma.